The Ophir Gottlieb Small Cap Biotech Index (Enhanced Index & ETF Coming Soon)

This isn't advice, this is information. Please read the legal disclosures at the end of this post.

-- The Need
True bio-tech growth exposure only achievable by eliminating market cap minimums, forcing equal weighted holdings, and substantially greater diversification.


-- How is this Different from the NASDAQ Biotechnology Index?


-- You can follow daily blog updates; Know Everything

1. Largest Stock Moves
2. Unusually High Option Volume
3. Unusually High Stock Volume
4. Index Value Changes

-- What About Performance? (Coming Soon: Ophir Gottlieb Enhanced Biotech Index & ETF)


The Enhancement is an application of machine learning and forensics that will change... everything. Details coming soon. It is NOT applied to the index right now -- this is just a basket of stocks to follow the small cap Biotech sector in a new and more transparent way.


-- What About Risk?
It's enormous... Failures and bankruptcies are common place. The standard deviation of returns is huge, with annual returns ranging from down 50% to up 150% for the entire index. But don't be mislead, the NASDAQ Biotech Index shows annual returns ranging from down 40% to up 130%. This is a risky place for any investment capital. But for those that want exposure, let's get it right.


-- Additional Selection criteria? (for Un-Enhanced Index)

• Stock Price Range: Any
• Number of Employees: Any
• Revenue: Any

Un-Enhanced Index Construction (enhanced index and ETF coming soon)

• Equal dollar weighted in each firm starting with the prices shown below.
• Starting Index Value (normalized) 100

Let's see how these firms due over time with all the disasters, bankruptcies, miracles, drug approvals, acquisitions, and everything in between.

Ophir Gottlieb Small & Micro Cap Bio Tech Index (Un-enhanced)




This is trade analysis, not a recommendation.

Follow @OphirGottlieb

Tweet


Legal Stuff:
Options involve risk. Prior to buying or selling an option, an investor must receive a copy of Characteristics and Risks of Standardized Options. Investors need a broker to trade options, and must meet suitability requirements.

The information contained on this site is provided for general informational purposes, as a convenience to the readers. The materials are not a substitute for obtaining professional advice from a qualified person, firm or corporation. Consult the appropriate professional advisor for more complete and current information. I am not engaged in rendering any legal or professional services by placing these general informational materials on this website.

I specifically disclaim any liability, whether based in contract, tort, strict liability or otherwise, for any direct, indirect, incidental, consequential, or special damages arising out of or in any way connected with access to or use of the site, even if I have been advised of the possibility of such damages, including liability in connection with mistakes or omissions in, or delays in transmission of, information to or from the user, interruptions in telecommunications connections to the site or viruses.

I make no representations or warranties about the accuracy or completeness of the information contained on this website. Any links provided to other server sites are offered as a matter of convenience and in no way are meant to imply that I endorse, sponsor, promote or am affiliated with the owners of or participants in those sites, or endorse any information contained on those sites, unless expressly stated.